EXAI — Exscientia Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
- $1.24bn
- $900.27m
- £20.08m
Annual cashflow statement for Exscientia, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.04 | -24.4 | -56.2 | -141 | -162 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.095 | 2.25 | 6.7 | -7.56 | 12.6 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 14.6 | -0.369 | 38.6 | 78.2 | 16.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7.03 | -21.4 | -6.7 | -60.5 | -118 |
| Capital Expenditures | -1.7 | -2.37 | -7.11 | -22.4 | -26.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -1.38 | -19.5 | -100 | 5.15 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.7 | -3.75 | -26.6 | -123 | -21.5 |
| Financing Cash Flow Items | — | — | — | -2.28 | -0.243 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.146 | 56.3 | 533 | -4 | -3.4 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.18 | 31.1 | 500 | -158 | -145 |